Wei-Hui Xie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Wei-Hui Xie has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Aimin Sun
Department of Radiology, Shanghai Children’s Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai 200120, China
1 shared publication - Bing-Hua Chen
Department of Radiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
1 shared publication - Chen Guo
Department of Radiology, Shanghai Children’s Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China
1 shared publication - Dongaolei An
Department of Radiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China
1 shared publication - Hai-Sheng Qiu
Diagnostic Imaging Center, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, 1678 Dong Fang Road, Shanghai 200127, PR China
1 shared publication - Jin-Yi Xiang
Department of Radiology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
1 shared publication
Latest Publications
- 27 May 2026
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 64 (2) , 550-562
Prognostic Value of a Cardiac Magnetic Resonance‐Derived Left Atrioventricular Coupling Index From Routine Cine Images in Dilated Cardiomyopathy: A Multicenter Study
Background: Accurate risk stratification in dilated cardiomyopathy (DCM) is challenging. Conventional markers like left ventricular ejection fraction (LVEF) and late gadolinium enhancement (LGE) fail to fully capture the pathophysiological interplay between left atrial (LA) and left ventricular (LV) remodeling. Purpose: To determine the prognostic value of a cardiac MRI‐derived left atrioventricular coupling index (LACI) to predict adverse outcomes in DCM and assess its incremental utility beyond conventional markers. Study Type: Retrospective. Population: 403 patients with DCM from two centers, randomly split into a training set ( n = 282, 70%) for model development and an internal validation set ( n = 121, 30%). Field Strength/Sequence: Balanced steady‐state free precession cine and inversion‐recovery prepared fast gradient‐echo (LGE) sequences at 1.5T and 3.0T. Assessment: LACI was quantified as (LA minimal volume/LV end‐diastolic volume) × 100% from routine cine images. LA/LV volumes, function, LGE, and global longitudinal strain (GLS) were assessed by blinded radiologists. The primary endpoint was a composite of all‐cause mortality or heart failure hospitalization. Statistical Tests: Student's t ‐test, Mann–Whitney U test, chi‐square test, Spearman's correlation, Cox regression, Kaplan–Meier analysis with log‐rank test, receiver operating characteristic analysis, C‐index, net reclassification improvement (NRI). A two‐sided p value < 0.05 was significant. Results: Over a median 43.6‐month follow‐up, 97 patients (24.1%) reached the primary endpoint. In the training set, elevated LACI (≥ 45.75%) was the strongest independent predictor (adjusted hazard ratio [HR] = 3.485, 95% CI 1.821–6.667). The LACI‐enhanced model (including NYHA class, LGE, GLS) achieved a C‐index of 0.804 (95% CI 0.774–0.835) in the training set, which remained robust in the validation set (C‐index = 0.824, 95% CI 0.751–0.897). Adding LACI to the baseline model significantly improved reclassification (continuous NRI = 0.102, 95% CI 0.043–0.161). Data Conclusion: LACI derived from routine cine images is strongly and independently associated with adverse outcomes in DCM and provides significant incremental prognostic value beyond established markers, supporting its potential as a practical risk stratification tool. Evidence Level: 3. Technical Efficacy: Stage 5.
- 27 May 2026
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 64 (2) , 550-562
Prognostic Value of a Cardiac Magnetic Resonance‐Derived Left Atrioventricular Coupling Index From Routine Cine Images in Dilated Cardiomyopathy: A Multicenter Study
Background: Accurate risk stratification in dilated cardiomyopathy (DCM) is challenging. Conventional markers like left ventricular ejection fraction (LVEF) and late gadolinium enhancement (LGE) fail to fully capture the pathophysiological interplay between left atrial (LA) and left ventricular (LV) remodeling. Purpose: To determine the prognostic value of a cardiac MRI‐derived left atrioventricular coupling index (LACI) to predict adverse outcomes in DCM and assess its incremental utility beyond conventional markers. Study Type: Retrospective. Population: 403 patients with DCM from two centers, randomly split into a training set ( n = 282, 70%) for model development and an internal validation set ( n = 121, 30%). Field Strength/Sequence: Balanced steady‐state free precession cine and inversion‐recovery prepared fast gradient‐echo (LGE) sequences at 1.5T and 3.0T. Assessment: LACI was quantified as (LA minimal volume/LV end‐diastolic volume) × 100% from routine cine images. LA/LV volumes, function, LGE, and global longitudinal strain (GLS) were assessed by blinded radiologists. The primary endpoint was a composite of all‐cause mortality or heart failure hospitalization. Statistical Tests: Student's t ‐test, Mann–Whitney U test, chi‐square test, Spearman's correlation, Cox regression, Kaplan–Meier analysis with log‐rank test, receiver operating characteristic analysis, C‐index, net reclassification improvement (NRI). A two‐sided p value < 0.05 was significant. Results: Over a median 43.6‐month follow‐up, 97 patients (24.1%) reached the primary endpoint. In the training set, elevated LACI (≥ 45.75%) was the strongest independent predictor (adjusted hazard ratio [HR] = 3.485, 95% CI 1.821–6.667). The LACI‐enhanced model (including NYHA class, LGE, GLS) achieved a C‐index of 0.804 (95% CI 0.774–0.835) in the training set, which remained robust in the validation set (C‐index = 0.824, 95% CI 0.751–0.897). Adding LACI to the baseline model significantly improved reclassification (continuous NRI = 0.102, 95% CI 0.043–0.161). Data Conclusion: LACI derived from routine cine images is strongly and independently associated with adverse outcomes in DCM and provides significant incremental prognostic value beyond established markers, supporting its potential as a practical risk stratification tool. Evidence Level: 3. Technical Efficacy: Stage 5.
- Open Access
- 18 December 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (24) , 3240
Pericardial Fat Radiomics to Predict Left Ventricular Involvement and Provide Incremental Prognostic Value in ARVC
Background/Objectives: To explore the predictive value of pericardial fat tissue (PFT) radiomics for left ventricular (LV) involvement and major adverse cardiac events (MACE) in arrhythmogenic right ventricular cardiomyopathy (ARVC). Methods: In this retrospective multicenter study, LV involvement was assessed using cardiac magnetic resonance (CMR). A radiomic score (RS) derived from PFT was developed to predict LV involvement. The predictive accuracy of the RS was evaluated through receiver operating characteristic (ROC) analysis. Additionally, multivariable Cox regression analysis was employed to assess the prognosis across the entire dataset. Kaplan–Meier survival curves were used to evaluate the association between RS and MACE. Results: A total of 122 patients (mean age, 44 years ± 17; 76 male) were included, 90 for a development set and 32 for an external test set. The RS demonstrated good predictive performance for LV involvement in both the development and external test sets, with area under the curve (AUC) values of 0.771 and 0.785, respectively. Moreover, a high RS (≥−0.38) was independently associated with MACE during a median follow-up of 5 years (hazard ratio, 3.452; p < 0.001). Based on the right ventricular ejection fraction (RVEF) and RS, a simplified risk score was developed to categorize patients into three groups: high-risk (RVEF ≤ 40%, RS ≥ −0.38), intermediate-risk (RVEF ≤ 40%, RS < −0.38 or RVEF > 40%, RS ≥ −0.38), and low-risk (RVEF > 40%, RS < −0.38). Conclusions: The PFT radiomics can predict LV involvement and be associated with MACE in ARVC patients.
- 18 December 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (24) , 3240
Open AccessPericardial Fat Radiomics to Predict Left Ventricular Involvement and Provide Incremental Prognostic Value in ARVC
Background/Objectives: To explore the predictive value of pericardial fat tissue (PFT) radiomics for left ventricular (LV) involvement and major adverse cardiac events (MACE) in arrhythmogenic right ventricular cardiomyopathy (ARVC). Methods: In this retrospective multicenter study, LV involvement was assessed using cardiac magnetic resonance (CMR). A radiomic score (RS) derived from PFT was developed to predict LV involvement. The predictive accuracy of the RS was evaluated through receiver operating characteristic (ROC) analysis. Additionally, multivariable Cox regression analysis was employed to assess the prognosis across the entire dataset. Kaplan–Meier survival curves were used to evaluate the association between RS and MACE. Results: A total of 122 patients (mean age, 44 years ± 17; 76 male) were included, 90 for a development set and 32 for an external test set. The RS demonstrated good predictive performance for LV involvement in both the development and external test sets, with area under the curve (AUC) values of 0.771 and 0.785, respectively. Moreover, a high RS (≥−0.38) was independently associated with MACE during a median follow-up of 5 years (hazard ratio, 3.452; p < 0.001). Based on the right ventricular ejection fraction (RVEF) and RS, a simplified risk score was developed to categorize patients into three groups: high-risk (RVEF ≤ 40%, RS ≥ −0.38), intermediate-risk (RVEF ≤ 40%, RS < −0.38 or RVEF > 40%, RS ≥ −0.38), and low-risk (RVEF > 40%, RS < −0.38). Conclusions: The PFT radiomics can predict LV involvement and be associated with MACE in ARVC patients.